MedPath

Comparison of PRISM III, PIM2 and PELOD Scoring Systems

Completed
Conditions
Congenital Heart Disease
Registration Number
NCT04848168
Lead Sponsor
Antalya Training and Research Hospital
Brief Summary

PRISMIII(Pediatric Risk of Mortality III), PIM2(Pediatric Index of Mortality 2) and PELOD(Pediatric Logistic Organ Dysfunction) are frequently used for predicting mortality and morbidity in general pediatric ICUs(Intensive Care Units). However, the effectiveness of these scoring sistems in a specific group patients undergoing congenital heart surgery(CHS) is unknown. In this study, the investigators aimed primarily to evaluate the success of these scoring systems in predicting mortality and morbiditiy in this specific group and to compare the scoring systems with eachother, and secondly to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Patients younger than 18 years of age who had undergone congenital heart surgery
Exclusion Criteria
  • emergency operations Patients staying in intensive care unit for less than 24 hours

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evaluate the success of PRISMIII, PIM2 and PELOD scoring systems in predicting mortality and morbidity3 months

Patients younger than 18 years of age who had undergone congenital heart surgery were evaluated on the first postoperative day in the ICU and parameters were recorded. PRISMIII and PELOD scores were calculated using the most abnormal values in the first 24 hours, and PIM2 score was calculated using the data within the first hour.

morbidity indicators3 months

Morbidity indicators were determined as the length of ICU stay, total hospital stay, re-intubation, surgical revision, complications and re-admission to the ICU.

clinical outcomes3 months

Clinical outcomes were determined as 7-day mortality and 30-day mortality.

Secondary Outcome Measures
NameTimeMethod
to evaluate the relationship of these systems with the STAT(STS-EACTS CHS Mortality Score) category3 months

STAT category was determined according to the surgical procedure.

Trial Locations

Locations (1)

siyami ersek TRH

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath